Steno Diabetes Center Copenhagen, which offers tailored diabetes treatment for people with diabetes, has today been proclaimed to be world leading and a role model from which other countries and healthcare systems can learn. It is the Global Coalition for Value in Healthcare of the World Economic Forum that bestowed upon Steno Diabetes Center Copenhagen to be a so-called Global Innovation Hub, as they have evaluated that Steno Diabetes Center Copenhagen is one of the world’s most advanced and innovative initiatives, which facilitate the development towards a more coherent and effective healthcare system that create value for people with diabetes.
“The treatment we provide at Steno Diabetes Center Copenhagen has reduced diabetes-related blindness close to zero. Another example is that, we have reduced diabetes-related leg amputations by 80%. These are amazing results that match our vision of offering people living with diabetes, prevention and treatment at the highest international level. We strive at creating a healthcare system with a human approach, and the setup at Steno Diabetes Center Copenhagen is a gold standard example of that, providing a framework for a good life for individuals living with a non-communicable disease. I am very proud of the recognition from the World Economic Forum, which shows that we are on the right track towards our vision for Steno Diabetes Center Copenhagen,” says Chairman of the Regional Council Sophie Hæstorp Andersen.
Steno Diabetes Center Copenhagen is a public-private partnership between the Capital Region of Denmark and the Novo Nordisk Foundation. The Novo Nordisk Foundation has donated 0.4 billion Euro for further development of the hospital, which was established by Doctor Hans Christian Hagedorn back in 1932. With the recognition from the Forum, Steno Diabetes Center Copenhagen enters a small group of world leading healthcare providers, each selected to be a showcase for the rest of the world in relation to disseminating examples of value-based healthcare with a sharp focus on creating the greatest possible value for the individual citizen.
“It is an amazing recognition of the important work being performed at Steno Diabetes Center Copenhagen and the other regional Steno Diabetes Centers. I hope that it will inspire others and accelerate innovation in the treatment of diabetes and other non-communicable diseases globally,” says Chairman of Board of Directors at Novo Nordisk Foundation Lars Rebien Sørensen.
Steno Diabetes Center Copenhagen has been selected as one of four international initiatives that will be part of the World Economic Forum’s work over the next two years to strengthen the spread of innovative health initiatives that create value for the individual with one or more chronic diseases.
“Non-communicable diseases, including diabetes, are major challenges for populations, healthcare systems and healthcare economies globally. Accordingly, there is a global need for health systems to move towards a cross-sectoral oriented collaboration that provides more healthy life years for citizens with non-communicable diseases, a high user satisfaction, as well as new solutions that are structurally and economically sustainable. We are proud that we have been selected as a proof-of-concept for innovation in healthcare and look forward to collaborating with other Global Innovation Hubs around the world, from whom we can certainly learn a lot”, says CEO at Steno Diabetes Center Copenhagen Allan Flyvbjerg.
The Capital Region of Denmark: press officer, Cell +45 7020 9588, email@example.com
The Novo Nordisk Foundation: Christian Mostrup Scheel, press officer, Cell: +45 3067 4805, firstname.lastname@example.org
Steno Diabetes Center Copenhagen, CEO Allan Flyvbjerg, Cell: +45 5177 9548, email@example.com
The World Economic Forum, committed to improving the state of the world, is the International Organization for Public-Private Cooperation. The Forum engages the foremost political, business and other leaders of society to shape global, regional and industry agendas. (www.weforum.org). Read more about the Forum’s Platform for Shaping the Future of Health and Healthcare: www.weforum.org/platforms/shaping-the-future-of-health-and-healthcare
The Global Coalition for Value in Healthcare, hosted by the World Economic Forum, is a public-private collaboration to accelerate value-based health system transformation. The Global Innovation Hub for Value in Healthcare serve as a collaboration platform.
Read more at: https://www.weforum.org/global-coalition-for-value-in-healthcare and https://www.weforum.org/global-coalition-for-value-in-healthcare/global-innovation-hub
The Capital Region of Denmark is with its 1.85 mio. inhabitants the largest of Denmark’s five politically managed regions. The Capital Region of Denmark offers the citizens of the region a cohesive healthcare system with a focus on running hospitals within somatic- and psychiatry diseases, as well as research and education. The Capital Region of Denmark also has a number of tasks in order to supporting the development in the region within the environmental, infrastructure, and the social area. The Capital Region has approximately 44,000 employees and a total annual budget of almost 5 billion Euro. The Capital Region of Denmark is partner in Greater Copenhagen.
Read more at: www.regionh.dk/english/Pages/default.aspx
The Novo Nordisk Foundation is an independent Danish foundation with corporate interests. It has two objectives: 1) to provide a stable basis for the commercial and research activities of the companies in the Novo Group; and 2) to support scientific, humanitarian and social causes.
The vision of the Foundation is to contribute significantly to research and development that improves the lives of people and the sustainability of society. Since 2010, the Foundation has donated more than 4 billion Euro, primarily for research at public institutions and hospitals in Denmark and the other Nordic countries as well as research-based treatment and prevention of diabetes.
Read more at: www.novonordiskfonden.dk/en
Steno Diabetes Center Copenhagen is an internationally leading diabetes hospital, established in 1932. Steno Diabetes Center Copenhagen is based in Greater Copenhagen, as a public-private partnership between the Capital Region of Denmark and the Novo Nordisk Foundation, which is supported by a donation of 0,4 billion Euro from Novo Nordisk Foundation the Novo Nordisk Foundation.
Steno Diabetes Center Copenhagen’s purpose is not only to improve the quality of the diabetes treatment in the Capital Region, but also nationally and globally to contribute to the development of new models for a value-based healthcare system. Steno Diabetes Center Copenhagen is Scandinavia’s largest diabetes hospital.
Read more at: https://www.sdcc.dk/english/Pages/default.aspx